Home > Financial Ratios > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SHUKRA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

SHUKRA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.77238.70121.1264.8116.13

What is the latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS is -23.77 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-23.77
Mar2024238.70
Mar2023121.12
Mar202264.81
Mar202116.13

How is Core EBITDA Growth of SHUKRA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.77
Negative
Mar2024 238.7
97.08
Mar2023 121.12
86.88
Mar2022 64.81
301.80
Mar2021 16.13 -

Other Financial Ratios of SHUKRA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹2,391.8 Cr 0.6% 30.2% 96.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,716.0 Cr 0.1% -0.6% 15.2% Stock Analytics
DIVIS LABORATORIES ₹248,120.0 Cr -0.6% 8.7% 53% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,038.0 Cr -0.8% -1.7% 34.7% Stock Analytics
CIPLA ₹110,858.0 Cr -0.6% -4.2% -12.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,828.7 Cr 2.7% -0.7% -12.1% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

0.6%

30.2%

96.6%

SENSEX

-0.6%

-4.4%

-8.7%


You may also like the below Video Courses